市場調查報告書
商品編碼
927852

去礦物質化骨基質全球市場:成長、趨勢、預測(2020年∼2025年)

Demineralized Bone Matrix Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

預估全球去礦物質化骨基質市場將在預測期間中以約5.5%的CAGR成長。骨科疾病發病率不斷上升、脊柱融合術及牙科手術增加、隨著人口成長的病患人數增加,預估將在預測期間內推動市場發展。去礦物質化骨基質廣泛使用於骨科手術中的各種應用,例如骨骼或關節疾病。由於骨骼衰弱引起的骨科疾病病例增加,預估將加速需求。根據世界衛生組織人口司數據,2015年60歲以上人口為9億人,預估2050年將達到20億人。因此,隨著易罹患骨科疾病老年人口的增加,預估骨科疾病的數量將進一步上升,市場於預測期間內的需求將激增。

去礦物質化骨基質提供的優點,如骨誘導性及骨引導性等大幅降低合併症發生率,為市場開闢了道路。

此外,使用去礦物質化骨基質保留天然骨組織必需的生化組成、結構、表面形貌之仿生生成、以及植入式微載體等的技術進步,近年來在產業成長方面扮演重要角色。除了材料、設計、以及同種移植技術的進步之外,因其被使用於各種複雜的手術,被認為是至關重要的開發。另一方面,去礦物質化骨基質的高成本將可能會阻礙市場發展。

本報告研究全球去礦物質化骨基質市場,彙整市場機會及趨勢、成長及阻礙因素、按區分及區域的市場分析、競爭情勢、主要企業簡介等情報。

目錄

第1章 前言

  • 研究假設
  • 研究範圍

第2章 研究方法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長因素
    • 骨科疾病發病率上升
    • 脊柱融合術和牙科手術增加
    • 隨人口增加而增長的病患人數
  • 市場阻礙因素
    • 去礦物質化骨基質的高成本
  • 波特五力分析
    • 新投入者的威脅
    • 買家/消費者交涉能力
    • 供應商交涉能力
    • 替代產品的威脅
    • 競爭劇烈程度

第5章 市場區分

  • 按產品類型
    • Gel
    • Putty
    • Putty with Chips
    • 其他
  • 按應用
    • 牙科
    • Craniomaxillofacial
    • 關節重建手術
    • 長骨
    • 脊柱融合術
    • 其他
  • 按區域
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲地區
    • 南美

第6章 競爭情勢

  • 企業簡介
    • Hans Biomed
    • Institut Straumann Ag
    • J &J (Depuy Synthes)
    • Medtronic
    • RTI Surgical Holdings, Inc
    • Seaspine
    • Stryker
    • Wright Medical Group NV
    • Xtant Medical
    • Zimmer Biomet

第7章 市場機會與未來趨勢

目錄
Product Code: 68269

The global demineralized bone matrix market studied was anticipated to grow with a CAGR of nearly 5.5% during the forecast period. Rising incidence of orthopedic disorders, increasing number of spinal fusion and dental surgeries, increasing patient base with growing population are the factors expected to drive the market during the forecast period. Demineralized bone matrix is widely used in orthopedic surgeries for numerous applications such as bone & joint disorders. Rising cases of orthopedic disorders caused due to weakened bones are projected to fuel demand. According to the world Health Organization, Population Division, the number of people aged over 60 was 900 million in 2015 and is expected to reach 2 billion in 2050. Thus, the number of orthopedic disorders is expected to grow with rising geriatric population prone to orthopedic ailments. Thus, the market is anticipated to witness significant demand during the forecast period.

The benefits provided by demineralized bone matrix such as osteoinductivity and osteoconductivity with a significantly lower complication rate pave a way for the market.

Furthermore, technological advancements such as formation of biomimetic and implantable microcarrier using demineralized bone matrix which preserves the essential biochemical composition, architecture and surface topography of natural bone tissue have played a principal role in industry growth during the recent years. Besides advancements in materials, designs, & allografting techniques are considered as a crucial development as they are used in various complex surgeries. However, high cost of demineralized bone matrix may hamper the market.

Key Market Trends

Spinal Fusion Segment Is Anticipated To Witness The Significant Growth Rate and is Expected to Continue to Do the Same during the Forecast Period

  • Spinal fusion segment is anticipated to witness the significant growth rate through the forecast period. Spinal fusion is used to correct defects in vertebrae of the spine. According to the European Spine Journal in 2017, De novo degenerative lumbar scoliosis is a spinal deformity in the elderly population that leads to disabiling LBP/leg pain and suboptimal quality of life. To curb this problem, demineralized bone matrix are being adopted as a treatment of choice for these spinal deformities.
  • Therefore increasing number of elderly population suffering from these spinal disorders and rising adoption of demineralized bone matrix procedure as a treatment method is anticipated to escalate the revenue for the segment over the forecast period.

North America Represents the Largest Market and Asia-Pacific is Expected to Register Fastest Growth.

North America captured the largest share in the global market. Awareness regarding the commercially available products, higher healthcare expenditure 17.7% in 2018, and availability of advanced healthcare infrastructure are the major factors contributing toward its growth. Government organizations such as North American Spine Foundation, initiated the campaign for awareness and educate healthcare professionals and public about treatment option that likely to drive growth. The U.S., in particular, is leading the global market by generating the maximum product demand on account of the high prevalence of orthopedic diseases and trauma-related injuries. These factors contribute to the segment's dominance throughout the forecast period.

Asia Pacific market is anticipated to witness the fastest growth over the forecast period. High level of population, developing economies, and increasing demand for advanced treatment options are factors anticipated to drive growth in the Asia Pacific region at the highest rate during the forecast period. In addition, favorable government policies such as China's healthcare reform and approval of 100 % foreign direct investment in medical devices sector by the Indian government have contributed to the growth of the market. These two countries along with Japan are expected to spearhead the growth of the regional market. For instance, the recent approval of Medtronic's grafton Demineralized Bone Matrix in Japan in 2019, the regional market is poised to register lucrative growth in this region over coming few years.

Competitive Landscape

The market is characterized by high competition based on price, product differentiation, and low cost of technology. It is also marked by increased focus on development of innovative products and a successful track record of mergers and acquisitions. Major manufacturers, raw material suppliers, and machinery manufacturers have been working in tandem to research, develop, and innovate new products within the field of allograft. Some of the key industry players are J &J (Depuy Synthes); Medtronic; Wright Medical Group N.V.; Zimmer Biomet and Stryker.

The entry of new players especially in market is expected to boost the market growth with huge untapped opportunities. In February 2019, Medtronic launched Grafton DBM in Japan, which was the first-ever DBM in this country. This initiative is expected to increase the company's regional penetration.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Orthopedic Disorders
    • 4.2.2 Increasing Number of Spinal Fusion and Dental Surgeries
    • 4.2.3 Increasing Patient Base With Growing Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Demineralized Bone Matrix
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Gel
    • 5.1.2 Putty
    • 5.1.3 Putty with Chips
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Dental
    • 5.2.2 Craniomaxillofacial
    • 5.2.3 Joint Reconstruction
    • 5.2.4 Long Bone
    • 5.2.5 Spinal Fusion
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Hans Biomed
    • 6.1.2 Institut Straumann Ag
    • 6.1.3 J &J (Depuy Synthes)
    • 6.1.4 Medtronic
    • 6.1.5 RTI Surgical Holdings, Inc
    • 6.1.6 Seaspine
    • 6.1.7 Stryker
    • 6.1.8 Wright Medical Group N.V.
    • 6.1.9 Xtant Medical
    • 6.1.10 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS